Connecticut CannaTimesFacts first. You decide.

HB 5222 Strips Hemp-Derived Minor Cannabinoid Protections on Its Way to the Senate

Buried inside HB 5222 is a little-noticed cannabis definition rewrite that could have major consequences for Connecticut’s hemp and cannabinoid market.

By Connecticut CannaTimesPublished

Part of HB 7181 and Connecticut's Enforcement Laws

In this storyGeneral Assembly

CT Cannatimes Staff - 5.6.2026

Buried inside HB 5222 is a little-noticed cannabis definition rewrite that could have major consequences for Connecticut’s hemp and cannabinoid market.

The bill removes language that previously excluded hemp-derived minor cannabinoids like cannabinol (CBN), cannabigerol (CBG), and cannabichromene (CBC) from the state’s cannabis definition.

The deleted language specifically removed from statute states:

“cannabinol, cannabigerol, cannabichromene or any other minor cannabinoid derived from hemp”

That carveout is now gone.

Instead, HB 5222 expands the cannabis definition to include:

* high-THC hemp products,

* manufactured cannabinoids,

  • and compounds “similar” to cannabidiol or cannabinol in structure or physiological effect if treated as controlled substances.

This raises a major question:

Why is Connecticut tightening control over cannabinoids that are generally understood to be non-intoxicating or only mildly psychoactive?

CBG, CBC, and many hemp-derived minor cannabinoids have commonly been marketed nationwide as wellness-focused compounds associated with:

* inflammation support,

* sleep products,

* mood support,

  • and non-intoxicating hemp formulations.

Unlike delta-9 THC, these compounds are not generally known for producing a strong intoxicating “high.”

Critics may now ask whether Connecticut is laying groundwork for:

* future restrictions on hemp-derived cannabinoid products,

* expanded DCP enforcement authority,

  • or pushing more cannabinoid commerce back into the licensed cannabis system.

The language is especially notable because the state simultaneously created a new State-Wide Cannabis, Hemp and Controlled Substances Enforcement Board focused on “illegal cannabis sales” and “intoxicating hemp product sales.”

Yet HB 5222 does not clearly explain why cannabinoids widely considered non-intoxicating needed to lose their statutory exclusion.

The practical impact of the change may ultimately depend on how aggressively DCP interprets and enforces the revised cannabis definition moving forward.

This story was originally published by Connecticut CannaTimes on Facebook on May 6, 2026 and was migrated to this website on October 16, 2026. The publication date above is the original date.

More in HB 7181 and Connecticut's Enforcement Laws

The full investigation
  1. SEC Executive Director Brandon McGee Added to the Statewide Cannabis and Hemp Enforcement Board
  2. HB 7181 Quietly Changed How Cannabis Rules Are Made in Connecticut
  3. HB 7181 Puts Home Growers' Doors in Reach of the DEA and State Police